| [1] |
The International Hap Map Consortium.The International Hap Map Project.Nature,2003,426:789-796.
|
| [2] |
Whiteside T L,Rabinowich H.The role of Fas/FasL in immunosuppression induced by human tumors.Cancer Immunol Immunother,1998,46:175-184.
|
| [3] |
Leithäuser F,Dhein J,Mechtersheimer G,et al.Constitutive and induced expression of APO-1,a new member of the nerve growth factor/tumor necrosis factor receptor superfamily,in normal and neoplastic cells.Lab Invest,1993,69:415-429.
|
| [4] |
Evan G I,Vousden K H.Proliferation,cell cycle and apoptosis in cancer.Nature,2001,411:342-348.
|
| [5] |
Nagata S,Golstein P.The Fas death factor.Science,1995,267:1449-1456.
|
| [6] |
Reichmann E.The biological role of the Fas/FasL system during tumor formation and progression.Semin Cancer Biol,2002,12:309-315.
|
| [7] |
Kase H,Aoki Y,Tanaka K.Fas ligand expression in cervical adenocarcinoma:relevance to lymph node metastasis and tumor progression.Gynecol Oncol,2003,90:70-74.
|
| [8] |
Ropponen K M,Eskelinen M J,Lipponen P K,et al.Prognostic value of tumour-infiltrating lymphocytes (TILs)in colorectal cancer.J Pathol,1997,182:318-324.
|
| [9] |
Müschen M,Warskulat U,Beckmann MW.Defining CD95 as a tumor suppressor gene.J Mol Med,2000,78:312-325.
|
| [10] |
Kurooka M,Nuovo G J,Caligiuri M A,et al.Cellular localization and function of Fas ligand (CD95L)in tumors.Cancer Res,2002,62:1261-1265.
|
| [11] |
Kordi Tamandani D M,Sobti R C,Shekari M.Association of Fas-670 gene polymorphism with risk of cervical cancer in North Indian population.Clin Exp Obstet Gynecol,2008,35:183-186.
|
| [12] |
Chen J Y,Wang C M,Ma C C,et al.The-844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.Genes Immun,2005,6:123-128.
|
| [13] |
杨燊,缪小平,张雪梅,等.凋亡相关基因Fas及其配体Fas L 基因单核苷酸多态与大肠癌风险.中华医学杂志,2005,85:2132-2135.
|
| [14] |
Sun T,Miao X,Zhang X,et al.Polymorphisms of death pathway genes Fas and Fas L in esophageal squamous-cell carcinoma.J Natl Cancer Inst,2004,96:1030-1036.
|
| [15] |
Zhang X,Miao X,Sun T,et al.Functional polymorphisms in cell death pathway genes Fas and Fas L contribute to risk of lung cancer.J Med Genet,2005,42:479-484.
|
| [16] |
Zhang B,Sun T,Xue L,et al.Functional polymorphisms in Fas and FasL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.Carcinogenesis,2007,28:1067-1073.
|
| [17] |
Sun T,Zhou Y,Li H,et al.FasL-844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.J Exp Med,2005,202:967-974.
|
| [18] |
Kang S,Dong S M,Seo S S,et al.Fas-1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer.Cancer Genet Cytogenet,2008,180:1-5.
|